Komori
Sinfonia Technology (6507) · FactInterim R&D expenses increased year on year

R&D Spending

First written in FY2018-Q3. 2 of 29 entries say "Restated". Latest entry: 2026-11-06.

29entries
9years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q3 – 2026-11-062018: 320182019: 420192020: 320202021: 420212022: 320222023: 320232024: 320242025: 220252026: 42026
Same theme, other companies
Continuation of Company-wide R&D Activities and Resource InvestmentA theme 221 companies write about · 0 as a headwind · 234 as a tailwind

95 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 236 threads.
Full recordFilings, disclosures and news, newest first
  1. 2026-11-06OtherResults

    「Research and development expenses amounted to ¥2.481 billion, an increase of ¥513 million from ¥1.968 billion in the same interim period of the previous year.」

    Interim research and development expenses increased by ¥513 million from the same interim period of the previous year.
  2. FY2027-H1Interim R&D expenses increased year on yearAnnual report

    「The total amount of research and development expenses for the interim consolidated accounting period was ¥2,481 million.」

    Interim research and development expenses were ¥2,481 million, an increase of ¥513 million, or approximately 26.1%, from ¥1,968 million in the same interim period of the previous year.
  3. FY2026Full-year research and development expenses increasedAnnual report

    「Total R&D expenses for the current consolidated fiscal year were ¥4,160 million.」

    Full-year R&D expenses were ¥4,160 million, an increase of ¥480 million from ¥3,680 million in the previous fiscal year. Development of semiconductors, aerospace, electrification, decarbonisation and logistics, among other areas, is being advanced.
  4. 2026-05-14OtherRevisions to earnings forecasts

    「Research and development expenses 3,680 4,160 479 13.0 %」

    Research and development expenses increased from ¥3.680 billion in the previous fiscal year to ¥4.160 billion.
  5. FY2026-H1Interim R&D expenses increased year on yearAnnual report

    「Total R&D expenses for the current interim consolidated accounting period were ¥1,968 million.」

    Interim R&D expenses were ¥1,968 million, an increase of ¥253 million from ¥1,715 million in the same interim period of the previous year.
  6. FY2025Full-year research and development expenses increasedAnnual report

    「Total R&D expenses for the current consolidated fiscal year were ¥3,680 million.」

    Full-year R&D expenses were ¥3,680 million, an increase of ¥260 million from ¥3,420 million in the previous fiscal year. Development of semiconductors, aerospace, electrification, decarbonisation and logistics, among other areas, is continuing.
  7. FY2025-H1Interim R&D expenses decreased year on yearAnnual report

    「Total R&D expenses for the current interim consolidated accounting period were ¥1,715 million.」

    Interim R&D expenses were ¥1,715 million, a decrease of ¥183 million from ¥1,898 million in the same interim period of the previous year.
  8. FY2024Full-year research and development expenses decreasedAnnual report

    「Total R&D expenses for the current consolidated fiscal year were ¥3,420 million.」

    Full-year R&D expenses were ¥3,420 million, a decrease from ¥3,894 million in the previous fiscal year. Meanwhile, development in new fields including semiconductors, logistics, regenerative medicine and decarbonisation is continuing.
  9. FY2024-Q3R&D expenses decreased year on yearAnnual report

    「Total R&D expenses for the 3rd quarter of the current consolidated cumulative period were ¥2,490 million.」

    R&D expenses for the cumulative 3rd quarter were ¥2,490 million, a decrease of ¥510 million from ¥2,800 million in the same period of the previous year.
  10. FY2024-Q2R&D expenses decreased year on yearAnnual report

    「Total R&D expenses for the 2nd quarter of the current consolidated cumulative period were ¥1,662 million.」

    R&D expenses for the cumulative 2nd quarter were ¥1,662 million, a decrease of ¥236 million from ¥1,898 million in the same period of the previous year.
  11. FY2024-Q1R&D expenses decreased year on yearAnnual report

    「Total R&D expenses for the 1st quarter of the current consolidated cumulative period were ¥768 million.」

    R&D expenses for the cumulative 1st quarter were ¥768 million, a decrease of ¥134 million from ¥902 million in the same period of the previous year.
  12. FY2023-Q3Research and development expenses increased year on yearAnnual report

    「Total R&D expenses for the 3rd quarter of the current consolidated cumulative period were ¥2,800 million.」

    R&D expenses for the cumulative 3rd quarter were ¥2,800 million, an increase from ¥1,962 million in the same period of the previous year.
  13. FY2023-Q2Research and development expenses increased year on yearAnnual report

    「Total R&D expenses for the 2nd quarter of the current consolidated cumulative period were ¥1,898 million.」

    R&D expenses for the cumulative 2nd quarter were ¥1,898 million, an increase of ¥332 million, or approximately 21.2%, from ¥1,566 million in the same period of the previous year.
  14. FY2023-Q1Research and development expenses increased year on yearAnnual report

    「Total R&D expenses for the 1st quarter of the current consolidated cumulative period were ¥902 million.」

    R&D expenses for the cumulative 1st quarter were ¥902 million, an increase of ¥323 million from ¥579 million in the same period of the previous year.
  15. FY2022-Q3Research and development expenses increased year on yearAnnual report

    「Total R&D expenses for the 3rd quarter of the current consolidated cumulative period were ¥1,980 million.」

    R&D expenses for the cumulative 3rd quarter were ¥1,980 million, an increase of ¥18 million from ¥1,962 million in the same period of the previous year.
  16. FY2022-Q2R&D expenses decreased year on yearAnnual report

    「Total R&D expenses for the 2nd quarter of the current consolidated cumulative period were ¥1,251 million.」

    R&D expenses for the cumulative 2nd quarter were ¥1,251 million, a decrease of ¥315 million from ¥1,566 million in the same period of the previous year.
  17. FY2022-Q1R&D expenses decreased year on yearAnnual report

    「Total R&D expenses for the 1st quarter of the current consolidated cumulative period were ¥579 million.」

    R&D expenses for the cumulative 1st quarter were ¥579 million, a decrease of ¥209 million from ¥788 million in the same period of the previous year.
  18. FY2021Full-year research and development expenses decreasedAnnual report

    「Total R&D expenses for the current consolidated fiscal year were ¥2,710 million.」

    Full-year R&D expenses were ¥2,710 million, a decrease of ¥370 million from ¥3,080 million in the previous fiscal year. However, development related to advanced technologies, electrification, AI and IoT, among other areas, is continuing.
  19. FY2021-Q3Research and development expenses increased year on yearAnnual report

    「Total R&D expenses for the 3rd quarter of the current consolidated cumulative period were ¥1,962 million.」

    R&D expenses for the cumulative 3rd quarter were ¥1,962 million, an increase of ¥114 million from ¥1,848 million in the same period of the previous year.
  20. FY2021-Q2R&D expenses decreased year on yearAnnual report

    「Total R&D expenses for the 2nd quarter of the current consolidated cumulative period were ¥1,295 million.」

    R&D expenses for the cumulative 2nd quarter were ¥1,295 million, a decrease from the ¥1,566 million disclosed for the same period of the previous year.
  21. FY2021-Q1R&D expenses decreased year on yearAnnual report

    「Total R&D expenses for the 1st quarter of the current consolidated cumulative period were ¥612 million.」

    R&D expenses for the cumulative 1st quarter were ¥612 million, a decrease of ¥176 million from ¥788 million in the same period of the previous year.
  22. FY2020-Q3Research and development expenses increased year on yearAnnual report

    「Total R&D expenses for the 3rd quarter of the current consolidated cumulative period were ¥2,253 million.」

    R&D expenses for the cumulative 3rd quarter were ¥2,253 million, an increase from the ¥1,848 million disclosed for the same quarter in the previous period.
  23. FY2020-Q2Research and development expenses increased year on yearAnnual report

    「Total R&D expenses for the 2nd quarter of the current consolidated cumulative period were ¥1,566 million.」

    R&D expenses for the cumulative 2nd quarter were ¥1,566 million, an increase from ¥1,151 million in the same period of the previous period.
  24. FY2020-Q1Research and development expenses increased year on yearAnnual report

    「Total R&D expenses for the 1st quarter of the current consolidated cumulative period were ¥788 million.」

    R&D expenses for the cumulative 1st quarter were ¥788 million, an increase of ¥220 million from ¥568 million in the same period of the previous year.
  25. FY2019Full-year research and development expenses increasedAnnual report

    「Total R&D expenses for the current consolidated fiscal year were ¥2,620 million.」

    Full-year R&D expenses were ¥2,620 million, an increase of ¥487 million from ¥2,133 million in the previous fiscal year.
  26. FY2019-Q3Research and development expenses increased year on yearAnnual report

    「Total R&D expenses for the 3rd quarter of the current consolidated cumulative period were ¥1,848 million.」

    R&D expenses for the cumulative 3rd quarter were ¥1,848 million, an increase of ¥228 million, or approximately 14.1%, from ¥1,620 million in the same period of the previous year.
  27. FY2019-Q2RestatedAnnual report

    「Total R&D expenses for the 2nd quarter of the current consolidated cumulative period were ¥1,151 million.」

    The company disclosed total R&D expenses of ¥1,151 million for the cumulative 2nd quarter.
  28. FY2019-Q1RestatedAnnual report

    「Total R&D expenses for the 1st quarter of the current consolidated cumulative period were ¥568 million.」

    The company disclosed R&D expenses of ¥568 million for the cumulative 1st quarter. The previous figure of ¥1,620 million was for the cumulative 3rd quarter, covering a different period.
  29. FY2018-Q3First statedAnnual report

    「Total R&D expenses for the 3rd quarter of the current consolidated cumulative period were ¥1,620 million.」

    The company disclosed total research and development expenses for the cumulative third quarter.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Sinfonia Technology yet. It last moved in the Results of 2026-11-06: "Other".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.